Investigating the neuroprotective effect of erythropoietin in severe brain trauma
Phase 3
Recruiting
- Conditions
- Severe brain trauma.
- Registration Number
- IRCT20230901059316N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 136
Inclusion Criteria
Patients with brain trauma with GCS consciousness less than eight who have been treated medically
Less than six hours have passed since the patient's trauma
Exclusion Criteria
Chronic coagulation disorders
Chronic kidney disease
History of DVT and pulmonary embolism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of erythropoietin on increased alertness is measured by periodic examinations based on a score from GCS (Glasgow coma scale). Timepoint: Six weeks and six months after the intervention. Method of measurement: Glasgow coma scale ,Glasgow outcome scale.
- Secondary Outcome Measures
Name Time Method